ALXO - Latest News
ALX Oncology Holdings Inc. (ALXO), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $274.5M. Beta to the broader market is 0.45.
The article list below shows the most recent ALXO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ALXO Headlines
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
globenewswire.com - Jun 30, 2026
SOUTH SAN FRANCISCO, Calif. , June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc.
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
globenewswire.com - Jun 30, 2026
Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph. D.
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
globenewswire.com - Jun 30, 2026
Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph. D.
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
globenewswire.com - Jun 1, 2026
SOUTH SAN FRANCISCO, Calif. , June 01, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc.
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
zacks.com - May 12, 2026
Here is how ALX Oncology Holdings Inc. (ALXO) and Biodesix, Inc.
How News Affects ALXO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ALXO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ALXO news questions
- What is the latest ALXO news headline?
- The most recent ALXO headline (Jun 30, 2026) is "ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ALXO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ALXO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ALXO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.